Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Malaria Vaccine GSK 257049 in Infants
NCT00436007Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2007
- Primary completion
- Sep 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of RTS,S in malaria, sponsored by GSK. Started Apr 2007; status: completed.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00436007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436007.